MarketCap
Facebook
X
TelegramFluidigm Corporation Retained Earnings | FLDM
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -624 M | -559 M | -500 M | -439 M | -363 M | -310 M | -257 M | -241 M | -222 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -222 M | -624 M | -391 M |
Retained Earnings of other stocks in the Diagnostics research industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-294 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Waters Corporation
WAT
|
10.4 B | $ 476.29 | -0.09 % | $ 28.4 B | USA |
 |
Exagen
XGN
|
-314 M | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Celcuity
CELC
|
-449 M | $ 67.13 | -4.11 % | $ 3.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.64 B | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
680 M | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-719 M | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
-460 M | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
1.39 B | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
9.24 B | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Danaher Corporation
DHR
|
46.9 B | $ 236.19 | 0.46 % | $ 168 B | USA |
 |
RadNet
RDNT
|
-95.4 M | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-1.02 B | $ 10.05 | 2.55 % | $ 419 M | USA |
 |
Neuronetics
STIM
|
-459 M | $ 2.01 | -7.8 % | $ 133 M | USA |
 |
T2 Biosystems
TTOO
|
-584 M | - | -39.35 % | $ 313 K | USA |
 |
Thermo Fisher Scientific
TMO
|
59.2 B | $ 719.09 | -0.35 % | $ 271 B | USA |
 |
Biocept
BIOC
|
-298 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-2.99 B | $ 155.43 | -2.12 % | $ 19.5 B | USA |
 |
Akumin
AKU
|
-280 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-98.4 M | $ 10.63 | -8.68 % | $ 361 M |  Israel |
 |
VolitionRx Limited
VNRX
|
-253 M | $ 0.19 | -6.2 % | $ 23.9 M |  Singapore |
 |
Natera
NTRA
|
-2.78 B | $ 311.81 | -1.92 % | $ 42.6 B | USA |
 |
IQVIA Holdings
IQV
|
7.42 B | $ 275.46 | -1.21 % | $ 47.4 B | USA |
 |
Agilent Technologies
A
|
1.39 B | $ 178.84 | -0.74 % | $ 50.8 B | USA |
 |
Quotient Limited
QTNT
|
-725 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Chembio Diagnostics
CEMI
|
-154 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-424 M | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
75.7 M | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
-4.83 B | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
168 M | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-154 M | - | -34.28 % | $ 263 K | Israel |
 |
Heska Corporation
HSKA
|
-169 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-230 M | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
-212 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
-18.6 M | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
223 M | - | - | $ 1.49 B | USA |
 |
DexCom
DXCM
|
2.43 B | $ 79.92 | -1.42 % | $ 31.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.99 B | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-224 M | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
6.39 B | $ 696.77 | -1.4 % | $ 56 B | USA |
 |
Illumina
ILMN
|
-392 M | $ 214.84 | -2.69 % | $ 33.3 B | USA |
 |
Anixa Biosciences
ANIX
|
-252 M | $ 3.05 | -3.48 % | $ 99 K | USA |
|
Biodesix
BDSX
|
-498 M | $ 10.04 | -2.95 % | $ 75.8 M | USA |
 |
BioNano Genomics
BNGO
|
-720 M | $ 1.25 | 7.66 % | $ 6.81 M | USA |
 |
Bioventus
BVS
|
-335 M | $ 11.18 | 1.5 % | $ 745 M | USA |
 |
Fulgent Genetics
FLGT
|
530 M | $ 25.83 | -1.22 % | $ 795 M | USA |
 |
CareDx, Inc
CDNA
|
-735 M | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-84 M | - | - | $ 562 M | Britain |
 |
Biomerica
BMRA
|
-56.9 M | $ 1.48 | -4.52 % | $ 4.31 M | USA |